Vertex Pharmaceuticals Incorporated has unveiled significant progress in its suzetrigine pain program potentially marking a breakthrough in acute and neuropathic pain treatment Suzetrigine an oral selective

PharmaTher Holdings Ltd a specialized pharmaceutical firm has received a Complete Response Letter regarding its Priority Original Abbreviated New Drug Application

Evaxion Biotech AS a clinicalstage TechBio company specializing in AIImmunology powered vaccines has achieved a significant milestone in its EVX Phase trial for metastatic melanoma

ABVC BioPharma Inc has unveiled a significant licensing deal with OncoX a company specializing in oncology dietary supplements with the goal of advancing treatments for NonSmall Cell Lung Cancer

TaiGen Biotechnology Company Limited has announced today that its business partner Joincare Pharmaceutical has concluded the unblinding process for the phase III study of the influenza antiviral TG Initial findings indicate that TG significantly reduced the median time for alleviation of all influen...

Precision BioSciences Inc a leading gene editing company has declared the anticipated return of three programs previously under Prevail Therapeutics Inc a subsidiary of Eli Lilly and Company

RevolKa Ltd a venturebacked biotech company providing a gamechanging protein engineering technology platform and La Jolla Institute for Immunology agreed to start a research collaboration to create antigens for the nextgeneration vaccines to deliver innovative solutions

YS Biopharma Co Ltd a global biopharmaceutical company dedicated to discovering developing manufacturing and delivering new generations of vaccines

IMUNON Inc a clinicalstage drugdevelopment company focused on developing nonviral DNAmediated immunotherapy and nextgeneration vaccines announces receipt of clearance from the US Food and Drug Administration to begin a Phase clinical trial with a seasonal COVID booster vaccine

DiaMedica Therapeutics Inc a clinicalstage biopharmaceutical company focused on developing novel treatments for neurological disorders and cardiorenal disease today announced the first patient

Essential Pharma an international specialty pharma group focused on ensuring that patients have sustainable access to low volume clinically differentiated niche pharmaceutical products across key

Clearmind Medicine Inc a biotech company focused on discovery and development of novel psychedelicderived therapeutics to solve major undertreated health problems today announced an